Podcasts about Tract

Jeff Smith and Carson Odegard sit down with waterfowl historian Yancey Forest-Knowles to unpack the Sacramento–San Joaquin Delta—its island clubs, levees and tides, and the public access that still lets you chase mallards and specks on big water today.What you'll hearHow the Delta was built — from early private island claims and hand-built levees to today's twin pressures of saltwater intrusion and export pumping.Club lore & big names — Twitchell Island's first club (1880), Venice and Mandeville's eras, and the “Mallard Hole” stories tied to Barron Hilton and Hollywood guests.Flood risk is real — why peat islands subside and how Jones Tract's 2004 failure floated a clubhouse away.Public opportunity — boat-in spots and state-permitted floating blinds at Frank's Tract (plus Big Break, Stone Lakes, Decker & more), and the on-water etiquette that keeps it working.Access rules that matter — anchor next to levees to hunt, but don't set foot on them.Today's mix of ag & restoration — CWA ownership on Quimby and habitat work across Medford, Sherman, and sister islands.From 19th-century market hunts to modern floating blinds, this one maps the Delta's history and gives practical pointers for anyone looking to do it right on big water.

Featuring perspectives from Dr Haley Ellis and Dr James J Harding, including the following topics:  Introduction: Is Biliary Tract Cancer (BTC) the New Non-Small Cell Lung Cancer? … Why? (0:00) Case: A woman in her mid 70s with metastatic cholangiocarcinoma receives first-line gemcitabine/cisplatin with durvalumab — Warren S Brenner, MD (8:42) Case: A man in his late 70s with metastatic biliary cancer (HER2 IHC 2+) discontinues first-line chemotherapy/immunotherapy because of exacerbation of Crohn's disease — Neil Morganstein, MD (17:48) Case: A man in his early 70s with metastatic cholangiocarcinoma (FGFR2 rearrangement) receives gemcitabine/oxaliplatin with durvalumab and experiences a rapid clinical decline — Kimberly Ku, MD (27:14) Case: A woman in her late 40s with Stage IV recurrent cholangiocarcinoma (FGFR2 rearrangement) receives pemigatinib — Justin Peter Favaro, MD, PhD (40:15) Case: A woman in her early 60s with HER2-positive cholangiocarcinoma develops metastatic disease during adjuvant capecitabine therapy — Dr Morganstein (46:09) CME information and select publications

Lorenza Rimassa, MD - Shifting the Paradigm in Biliary Tract Cancers: Contemporary Data and Decision-Making

On a scale of five stars, how sure are you of going to heaven? If you cannot choose five stars, then you need to read this gospel tract.

Energetic Health Institute Radio with Angela Bulaga CHN – Brain fog, fatigue, GI issues (gas, bloating, nausea, vomiting, constipation, diarrhea). Oral thrush (white patches in the mouth and throat, soreness, and in the corners of the mouth), vaginal yeast infections (itching, burning, and discharge), jock itch, and anal itching. Athletes' foot, skin rashes (Eczema; Red, moist, or scaly rash, sometimes in...

Should a Christian get body piercings? Pierced ears? Pierced nose? Pierced eyebrows? Pierced tongue? Pierced lips? Pierced cheeks? Other piercings? Does the Bible even address this subject? Yes it does.

In today's episode, we had the opportunity to speak with Arndt Vogel, MD, about the European Commission's (EC's) July 2025 marketing authorization of zanidatamab-hrii (Ziihera) for the treatment of adult patients with previously treated, unresectable, locally advanced or metastatic HER2-positive biliary tract cancer. Dr Vogel is a faculty member at the University of Toronto Institute of Medical Science, a scientist at the Toronto General Hospital Research Institute, and a medical oncologist at the UHN–Princess Margaret Cancer Centre in Canada. In our exclusive interview, Dr Vogel highlighted the clinical importance of this decision, emphasizing that it represents a significant advancement for a molecularly defined subgroup of patients with limited treatment options and historically poor outcomes. He explained that biliary tract cancers, including cholangiocarcinoma, are associated with high recurrence rates and poor survival, even in patients who undergo curative-intent surgery. For patients in the advanced setting, second-line chemotherapy offers modest clinical benefit, with objective response rates of approximately 6%, a median progression-free survival of approximately 3 months, and a median overall survival of approximately 12 months. Vogel discussed the data supporting the EC's approval, which was based on findings from the phase 2b HERIZON-BTC-01 trial (NCT04466891)—the largest study conducted to date evaluating HER2-directed therapy in this patient population. In the trial, at a median follow-up of 21.9 months, patients with centrally confirmed HER2-positive tumors (n = 80) who received zanidatamab achieved a confirmed objective response rate (cORR) of 41.3% (95% CI, 30.4-52.8). The median duration of response was 14.9 months (95% CI, 7.4-not reached), and the median overall survival reached 15.5 months (95% CI, 10.4-18.5).

Does it seem that sin has destroyed your life? You need to listen to the true life story of Jim Costigan. The Lord Jesus Christ can cleanse you and save you from the deepest and most wretched sin.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will be available until June 29, 2026.Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy & Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from Incyte Corporation, Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will be available until June 29, 2026.Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy & Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from Incyte Corporation, Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will be available until June 29, 2026.Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy & Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from Incyte Corporation, Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will be available until June 29, 2026.Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy & Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from Incyte Corporation, Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will be available until June 29, 2026.Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy & Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from Incyte Corporation, Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will be available until June 29, 2026.Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy & Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from Incyte Corporation, Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will be available until June 29, 2026.Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy & Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from Incyte Corporation, Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.

Biliary tract cancer (BTC) presents a complex puzzle for the interprofessional healthcare team. With its diverse subtypes and unique molecular features, diagnosis and treatment require a personalized approach. Stay ahead of the curve with insights from leading experts, Dr. Anjana Pillai and Dr. Rachna Shroff, as they explore the latest genomic research, targeted therapies, and emerging treatment strategies in this dynamic podcast. Listen now to hear the Multidisciplinary Task Force perspective and strategies to optimize patient care in this rapidly evolving landscape. Click here to claim your credit for this podcast:

With so many treatment modalities for upper tract urothelial carcinoma, how does new evidence inform optimal care? In this episode of BackTable Tumor Board, urologic oncologist Dr. Nirmish Singla (Johns Hopkins), medical oncologist Dr. Jeannie Hoffman-Censits (Johns Hopkins), and urologic oncologist Dr. Bogdana Schmidt discuss treatment and diagnosis of upper tract urothelial carcinoma (UTUC). --- This podcast is supported by: Ferring Pharmaceuticalshttps://ad.doubleclick.net/ddm/trackclk/N2165306.5658203BACKTABLE/B33008413.420220578;dc_trk_aid=612466359;dc_trk_cid=234162109;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;gdpr=${GDPR};gdpr_consent=${GDPR_CONSENT_755};gpp=${GPP_STRING_755};gpp_sid=${GPP_SID};ltd=;dc_tdv=1 --- SYNPOSIS The discussion covers real-world UTUC cases, highlighting diagnostic challenges, treatment options, and evidence-based management strategies. They address scenarios ranging from localized to advanced UTUC, the role of systemic therapies, perioperative treatments, and the potential for novel approaches with immune checkpoint inhibitors. The episode underscores the evolving landscape of UTUC treatment and the importance of clinical trials and emerging biomarkers in improving patient outcomes. --- TIMESTAMPS 00:00 - Introduction 02:49 - Case Study 1: 66-Year-Old Male with UTUC11:19 - Case Study 2: 73-Year-Old Male with High-Grade Urothelial Carcinoma28:11 - Intravesical Chemotherapy Protocols30:44 - Case Study 3: 57-Year-Old Male with Recurrent Urothelial Cancer41:25 Clinical Trials and Emerging Treatments45:40 Case Study: 55-Year-Old Female with Bulky Lymphadenopathy 56:45 Concluding Remarks and Future Directions --- RESOURCES Society of Urologic Oncologyhttps://suonet.org/home.aspx

Chapel Hill Mayor Jess Anderson spoke with 97.9 The Hill's Andrew Stuckey on Thursday, May 23, discussing town news and events. She talked about a proclamation honoring Bill Massengale, gave an update on the town's budget conversation including feedback and timeline. She also gave an update on the Greene Tract, discussing the next steps as the town partners with Carrboro and Orange County to eventually develop the area into a large park and housing. She discussed some upcoming weekend events and more. The post Chapel Hill: Honoring Bill Massengale, Budget Updates, Greene Tract appeared first on Chapelboro.com.

Join our Urology colleagues, Dr. Melao and Dr. Spiess, as they discuss upper tract urothelial carcinoma—from risk stratification to management strategies in both low-risk and high-risk, high-grade settings. They'll also explore long-term renal function outcomes, a topic on which Dr. Spiess has recently published.

In this episode, we review the high-yield topic of⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Gastrointestinal Tract Histology⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Gastrointestinal section.Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbullets

On this episode of the podcast the grid makes the travel across the pond to Italy for the FORMULA 1 AWS GRAN PREMIO DEL MADE IN ITALY E DELL'EMILIA-ROMAGNA 2025 (say that 10 times fast). Tract prixview, gambling predictions, and Italian fun facts. Enjoy!

Hi, I'm John Sorensen, President of Evangelism Explosion International, and you're listening to Share Life Today. If you've seen someone leave a Gospel tract in a restaurant or hand one to a stranger walking by, have you ever thought, “I wonder if they'll read it?” I'd like to suggest that our first and best response should be to ask the Holy Spirit to compel the person to read it as He did with Philip. Philip was sitting on a park bench talking on his phone when someone walked by and handed him a Gospel tract. The Holy Spirit prompted Philip to open it. So he did, and he read the whole thing. Romans 3:23 jumped off the page, “For the wages of sin is death, but the gift of God is eternal life through Christ Jesus our Lord.” Philip was convicted, and he repented. Now, it just so happened that he read EE's Do You Know For Sure? tract. Philip has since ordered them and started a tract ministry. For a free online Gospel tract you can use wherever you go plus other resources and tips for sharing your faith, visit our website at sharelife.today.

Hi, I'm John Sorensen, President of Evangelism Explosion International, and you're listening to Share Life Today. Should we still use tracts for evangelism? As I walked toward the meeting hall at a conference, I saw one of the security guards sitting and reading our “Do You Know For Sure” tract. I went over and asked him, “Do you understand what you're reading?” And he said, “How can I unless someone explains it to me?” Immediately, I thought of the story of the Ethiopian eunuch when he met Philip on the road to Gaza. And just like the Bible story, this security guard listened carefully to the Gospel and gave his heart to Jesus Christ right there. And recently, we held a workshop to teach Christians how to share their faith, which they went out and did that very day! A few days later, a man called to tell us that he had made a decision to put his trust in Jesus through a tract that a team left with him. Tracts can be a great tool for us use to share our faith. For more information on how you can share your faith, visit our website at sharelife.today.

Welcome to the emDOCs.net podcast! Join us as we review our high-yield posts from our website emDOCs.net.Today on the emDOCs cast with Rachel Bridwell, MD, and Brit Long, MD (@long_brit), we cover left ventricular outflow tract obstruction, or LVOTO. To continue to make this a worthwhile podcast for you to listen to, we appreciate any feedback and comments you may have for us. Please let us know!Subscribe to the podcast on one of the many platforms below:Apple iTunesSpotifyGoogle Play

Hi, I'm John Sorensen, President of Evangelism Explosion International, and you're listening to Share Life Today. You know, it's unthinkable. It's February 1975, in Fort Lauderdale, Florida. You leave a Gospel tract with a young gas station attendant you come across while you're filling your tank. He takes the tract, shoves you, gives you an earful; and while you're stammering for words, he walks away. Now, if you're someone who likes to hand out Gospel tracts, you've probably never had an experience quite like that, but I'll bet you've still wondered if the people you give these tracts to actually read them or they toss them. Hey, we all have. In fact, some people will argue that Gospel tracts simply don't work. But let's get back to the young gas station attendant. His name is Jeff, and forty years later, he reaches out to us to find the person who gave him that Gospel tract. Through it, he accepted Jesus as His Savior, and his life was forever changed. For a free online Gospel tract you can use wherever you go, visit our website at sharelife.today.

WUPF || UMPJ || The year 2025 session of World University of Prayer and Fasting Course for CEMAC Zone and Nigeria in Ndoumbi. From 30th April to 7th of May 2025

TAKEAWAYSAre you an active follower of Christ or just a Sunday morning believer? Your children are watchingYou get to choose what your kids are going to be exposed toYou can't completely isolate your children from culture; you have to prepare them to serve in it somehowNo matter how old or how young you are, God hears your prayersChildren can absolutely lead people to Christ just as well as adults can

Alfredo Morabia and Vickie Mays (UCLA), editors at the American Journal of Public Health (AJPH) conducted an in-person interview of David Rein of the Atlanta Public Health Department focusing on improving vision and eye health using the CDC national Vision and Eye Health surveillance system to increase public awareness of affordable eye care.

Welcome to another episode of the Oncology Brothers podcast! In this episode, Drs. Rohit and Rahul Gosain, both practicing community medical oncologists, continue their discussion on HER2-positive biliary tract cancer. They are joined by Dr. Shubham Pant from MD Anderson, who shares his expertise on this rapidly evolving field. In this episode, we cover: •⁠  ⁠The importance of HER2 testing in biliary tract cancers, including intrahepatic and extrahepatic cholangiocarcinomas and gallbladder cancers. •⁠  ⁠Who should be tested for HER2 positivity and how to classify HER2-positive disease. •⁠  ⁠The role of next-generation sequencing (NGS) and immunohistochemistry (IHC) in determining HER2 status. •⁠  ⁠Current treatment options for HER2-positive biliary tract cancer, including the latest clinical trials and approved therapies like trastuzumab deruxtecan and zanidatamab. •⁠  ⁠The significance of patient-centered decision-making and managing side effects associated with these treatments. •⁠  ⁠Insights into the potential for brain metastases in biliary tract cancer and the importance of ongoing surveillance. Join us as we delve into the latest data and strategies for managing HER2-positive biliary tract cancer, and stay tuned for our next episode where we will discuss side effects and management of these therapies. Accreditation/Credit Designation Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource®, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgment of Commercial Support This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc. Link to gain CME credits from this activity: https://www.gotoper.com/courses/from-bench-to-bedside-paradigm-shifts-in-her2-metastatic-btc-treatment Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to like, subscribe, and hit the notification bell for more updates from the Oncology Brothers!

Are you using the best approach for patients with HER2-positive biliary tract cancer (BTC)?   Credit available for this activity expires: 4/30/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002492?ecd=bdc_podcast_libsyn_mscpedu

Featuring perspectives from Dr Mitesh J Borad and Dr Amit Mahipal, including the following topics: Introduction (0:00) Targeted Therapeutic Approaches for Patients with Biliary Tract Cancers (BTCs) — Dr Mahipal (4:59) Integration of Immune Checkpoint Inhibitors into Current BTC Management — Dr Borad (32:16) CME information and select publications

Clinical investigators discuss available data guiding the management of biliary tract cancers.  CME information and select publications here.

Clinical investigators discuss available data guiding the management of biliary tract cancers.  CME information and select publications here.

Welcome to the Oncology Brothers podcast! In this episode, Drs. Rohit and Rahul Gosain are joined by Dr. Ghassan Abou-Alfa, a medical oncologist specializing in the hepatobiliary space at Memorial Sloan Kettering. Together, they explored the current treatment landscape of biliary tract cancer, focusing on the advancements in HER2-driven therapies.   Key topics discussed included: • The evolution of treatment options for biliary tract cancer, including chemotherapy and immunotherapy. • The significance of genetic testing, including IDH1 mutations, FGFR alterations, and HER2 status. • The role of multidisciplinary collaboration in managing hepatobiliary cancers. • Insights into the latest clinical trials and emerging therapies for HER2-positive biliary tract cancer.   Join us as we delve into the complexities of biliary tract cancer and the promising developments in HER2-targeted treatments. Don't forget to check out our next episode, where we will take a deeper dive into the data surrounding HER2 therapies and discuss management strategies for common side effects.   YouTube: https://youtu.be/pGiU7JJGNOc   Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/   Subscribe to stay updated on the latest in oncology! #OncologyBrothers #BiliaryTractCancer #HER2 #CancerTreatment #MedicalOncology #CME #Podcast

Commentary by Dr. Jian'an Wang.

Dean covers resurfacing an outdoor spa and to prevent it from collapsing. Dean advices a caller on what to do with his plant ledges in his tract home. Dean helps a caller figure out what is causing their whole house water filter from working properly. Plus, Dean talks about restoring stamped concrete and what to avoid. Plus, Eaton Fire phase two clean up and aftermath. 

Dean continues with part two of big tract remodeling and recap's part one's important mentions. Dean recaps a bit of part one's  show to help set up part two. Dean talks turning windows into sliding doors, as it instantly provides natural lights into a tract home without creating any more holes. Lastly, new garage doors in tract homes and how it could change the visual appeal of a home. 

Dean addressed the weaknesses of tract homes, reducing and removing soffits. Dean says to get an inspection camera as it's a helpful tool when planning a remodel. Dean talks about relocating chandeliers and how a fireplace could screw up the living room's improvements (design by demolition). Last, Dean finishes his key elements when it comes to remodeling tract homes. 

This weekend, Dean talks small bets with major pay offs when it comes to remodeling tract homes. Dean covers the weaknesses of tract homes when remodeling them and how tract developments are the reason why many people can purchase a home. He shares how the largest weakness of a tract home is in fact, the orientation of the lot. Lastly, Dean says not to jump fundamentals and to obey them when remodeling a tract home.  

Dean advices on how to layout a steamed shower and building a wraparound porch on a tiny house. Dean helps a caller on locating California native drought tolerate plants that would go well with either gravel or decomposed granite. Dean says that most tract homes have four different developments and how the developers tend to flip them, change the placement to create an illusion of varies homes for the neighborhood; to make it look full. Plus, he recaps on the craftsmanship, the engineering and the developments of architecture pedigree of tract homes. 

Perhaps it's no coincidence that an infusion of spinach leaves has evidently been used since ancient times to treat respiratory symptoms.

Featuring perspectives from Prof John Bridgewater, including the following topics: Introduction: Biology and Epidemiology; Classification (0:00) Localized Biliary Tract Cancers (6:25) First-Line Treatment of Metastatic BTC (20:04) HER2-Positive Advanced BTC (24:22) Management of Mixed Hepatocellular Carcinoma/BTC Tumors (43:18) Advanced Cholangiocarcinoma with an FGFR2 Fusion (47:59) Other Important Issues in BTC (52:33) CME information and select publications  

Dr John Bridgewater from the UCL Cancer Institute in London, United Kingdom, discusses patient cases and summarizes current treatment approaches for cholangiocarcinoma and other biliary tract cancers. CME information and select publications here.

In today's episode, we had the pleasure of speaking with Rachna Shroff, MD, MS, FASCO, about the phase 3 SWOG S1815 trial (NCT03768414) evaluating the addition of nab-paclitaxel (Abraxane) to gemcitabine and cisplatin in patients with newly diagnosed, advanced biliary tract cancer. Dr Shroff of the interim clinical affairs director, the associate director of Clinical Investigations, and co-lead of the Gastrointestinal Clinical Research Team, at The University of Arizona Cancer Center. She is also a professor in the Department of Medicine, chief of the Division of Hematology/Oncology, medical director for the Oncology Service Line, and associate dean for Clinical and Translational Research at The University of Arizona College of Medicine in Tucson. In our exclusive interview, Dr Shroff discussed the rationale for this research, key efficacy and safety data from the trial, and the potentially wide-reaching future implications of these findings.

Whether you experience digestive discomfort, or just want to maximize your digestive potential and nutrient absorption, there is one amazing formula that covers all the bases. On this episode of Vitality Radio, Jared re-introduces his favorite product, Back On Tract, with a new and improved formulation that makes it an even bigger powerhouse than it was before. Back On Tract is designed as a comprehensive support for digestive health by combining digestive enzymes, probiotics, and system soothing herbs. Jared explains how these elements work together to enhance nutrient absorption, reduce digestive discomfort, and support overall gut health. The episode is rich with insights into the science behind digestive health and the benefits of the specific ingredients in the Back On Tract formula.Products:Back On TractAdditional Information:#341: Your Digestive Health Supplement User's Guide. From IBS to Acid Reflux - Learn How to Balance Your Gut Health With Natural Products.Visit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

In today's episode, we continue the section of the podcast series where we will go step by step through the Mass to look at the various sections and rubrics of the Liturgy. Now we turn to the Lessons, that is, the portion of the Mass that centers on the Epistle and Gospel. This also includes important elements such as the Alleluia or Tract and the Sermon. Moreover, we also examine the role of deacons and subdeacons during this part of the Mass. See all the episodes, and download resources: https://sspxpodcast.com/mass We'd love your feedback on this series! podcast@sspx.org – – – – – – View this episode on YouTube: https://youtu.be/ACUWzgSzDnk – – – – – – – The Society of Saint Pius X offers this series and all of its content free of charge. If you are able to offer a one time or a small monthly recurring donation, it will assist us greatly in continuing to provide these videos for the good of the Church and Catholic Tradition. Please Support this Apostolate with 1-time or Monthly Donation >> – – – – – – – Explore more: Subscribe to this Podcast to receive this and all our audio episodes Subscribe to the SSPX YouTube channel for video versions of our podcast series and Sermons FSSPX News Website: https://fsspx.news Visit the US District website: https://sspx.org/ – – – – – What is the SSPX Podcast? The SSPX Podcast is produced by Angelus Press, which has as its mission the fortification of traditional Catholics so that they can defend the Faith, and reaching out to those who have not yet found Tradition.  – – – – – – What is the SSPX? The main goal of the Society of Saint Pius X is to preserve the Catholic Faith in its fullness and purity, to teach its truths, and to diffuse its virtues, especially through the Roman Catholic priesthood. Authentic spiritual life, the sacraments, and the traditional liturgy are its primary means of bringing this life of grace to souls. Although the traditional Latin Mass is the most visible and public expression of the work of the Society, we are committed to defending Catholic Tradition in its entirety: all of Catholic doctrine and morals as the Church has always defended them. What people need is the Catholic Faith, without compromise, with all the truth and beauty which accompanies it. https://sspx.org

Sometimes we know all the things to do, but we just don't make it a priority to do them! On this episode of Vitality Radio, Jared shares just how true this can be for him as he shares his personal journey towards fitness and health, discussing the importance of accountability and mindset. He reflects on his past struggles with fitness, the motivation behind his new commitment, and the steps he is taking to improve his physical health. Additionally, he introduces an improved formulation of everyone's favorite, Back on Tract, and two exciting new products from Vitality Nutrition - EndoCleanse and LiverVitality!Products:Back on Tract - New and Improved Formula!LiverVitality - Brand New Formula!EndoCleanse - Brand New Formula! Additional Information:#493: The Mindset of Lasting Health and Fitness with Melissa VogelVitality Unleashed: Health Insights with Jared St. Clair | 255Visit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

Mouth noises. Jack reads for Frost & Fury. How to extort potential sponsors. Face tats for an edge. How to extort your college admissions. Jack reads for Justice Thomas. The Questionable Material Stock Market Report: Amazon, Proctor & Gamble, Merck. Jack reads for GroverClevelandBook. qmpodcast.com

BEST OF TST: The Kansas City Chiefs victory parade turned deadly and injurious to dozens of people on Valentine's Day, marking not only a shocking tragedy but a truly bloody Valentine. Strangely enough, the odd series of number patterns that appeared during Super Bowl weekend, were also present in reports of the shooting. Headline after headline reported different totals of victims - those injured, those killed, children, those being treated at hospitals - all in a manner where the numbers added to 22 and 25, the score of the big game, or to 13 or 33. These numbers appear in the inconsistent reports about the parade shooting: NBC News reported at 9:44am Thursday 15th, 23 injured and 2 taken into custody = 25. At 10:17am Yahoo reported 22 injured and 3 taken into custody = 25. An early article reported before arrests were announced that 22 were injured. The 3 arrested were out of a group of 10 questioned = 13, and 10-3 was the Halftime score of the Super Bowl. Such number synchronicity may not be a conspiracy, but instead a result of some influential force acting behind the scenes of human affairs - what Helena Blavatsky called the Secret Chiefs. The word ‘Chief' is also used in the ancient Jewish text called Talmud, where such a titled referred to anyone who stood against Israel, particularly the goyim, and how they should be killed. Tract 57a of the Talmud says their “ashes are gathered” and scattered, another odd link to Ash Wednesday.Maybe Joe Buck of ESPN, veteran play-by-play voice for "Monday Night Football," was on to something when he said this of the Super Bowl: "There's going to be some story. There's going to be something that happens because it's Vegas, and it won't stay in Vegas. It's going to be a big something that happens. I don't know what it is. I have no idea. I just think that is going to be a mess in my mind." Statement made by the KC Chiefs - calling the shooting “senseless violence” - and the KC Police Chief - “people who came to this celebration should expect a safe environment” - suggest we dismiss the motivations behind these events and further live in a fantasy where no violence ever occurs: remember when a homemade gun as used to kill former Japanese Prime Minister Shinzo Abe? The shootings took place in front of 800 officers, too, and it took a few bystanders to tackle a shooter despite laws against such gun violence. California's governor immediately vomited: “We need to pass a Constitutional Amendment to prevent gun violence nationwide.” The irony here is that the 2nd Amendment gave those bystanders the right to tackle one of the shooters. It's not the first shooting at a championship parade either, as others occurred in the wake of NBA and MLB celebrations as well. If violence of this sort of is planned by those other than ‘crazies', it would make far more sense to carry it out in the parade rather than the event itself since doing so would be too costly for the leagues, advertisers, etc. On our Super Bowl show, we discussed the ER in “super” and the “o” in Bowl and Champions being a different font than the rest of the letters. In Hebrew the strange E was two of the letters BET adding to 22, while the strange R was comprised of VAV and QOPH for a total 25. This was the score of the game. ERO is also the name of the god of love and passion we call cupid, who carries a bow and arrow (ero) - pronunciation reminds us of Arrowhead Stadium and the KC Chiefs logo. ERO is the quintessential Secret Chief, influencing our love from behind the scenes. Oddly, Valentine's Day was only 3 days after the Super Bowl. While 22 means ‘balance', the number 25 signifies a romantic passion associated directly with Valentine's Day and cupid or ERO.-FREE ARCHIVE (w. ads)SUBSCRIPTION ARCHIVEX / TWITTER FACEBOOKWEBSITEPAYPALCashApp: $rdgable EMAIL: rdgable@yahoo.com / TSTRadio@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/tst-radio--5328407/support.

BABY WE ARE BACK! In this episode, we talk about the chaos of January, what our plans are to make GUT TALK better than ever, upcoming projects like Jenna's launch of the 2nd round of TRACT (a 3 month program with her friend, Grayce) and the start of Jenna's CN-P program. The main focus is Jill's decision to mute every health influencer on social media due to the overwhelming and often contradictory health advice they spread. From claims that everything causes cancer to confusing messages about what's healthy, Jill discusses how this constant noise makes it hard to know what to trust. We explore the basics of staying healthy — sweating, lifting, eating real food, and focusing on what our bodies truly need. Plus, Jill shares her frustration with what she believes is wrong with health and wellness influencers. We wrap up with each of us sharing one thing we're doing this week to get our SH*T together!TRACT 3 MONTH PROGRAM: Starts February 23CN-P Program: 'GUTTALKGIRLS' for $200 off the programSponsor:LMNT Electrolytes LINK